Thus it may be that the concomitant autoimmune processes (non-neuronal autoantibodies were common) affect the serum antibody value, and it implies that high GAD-Ab values in patients with co-existing diabetes should not imply an immunotherapy responsive neurological disorder. The gene discussed is GAD1; the disease is nervous system disorder.